Looks like you clickedhttps://www.healio.com/hematology-oncology/leukemia/news/online/%7Ba31fb012-a9e5-44de-acdf-dbd471e64525%7D/ibrutinib-plus-cd19-specific-car-t-cell-therapy-may-benefit-patients-with-relapsed-or-refractory-cll
If you do not want to visit that page, you can close this browser tab.
